<div id="readability-page-1"><div><ul><li>LifeStance Health Group Inc reported quarterly breakeven results​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of seven analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -2 cents to -1 cents per share.</li><li>Revenue rose 16.3% to $363.81 million from a year ago; analysts expected $355.60 million. </li><li>LifeStance Health Group Inc's reported EPS for the quarter was breakeven results​.</li><li>The company reported quarterly net income of $1.08 million.</li><li>LifeStance Health Group Inc shares had risen by 13.6% this quarter and lost 15.2% so far this year.</li></ul>FORECAST CHANGES<ul><li>The mean earnings estimate of analysts had fallen by about 40% in the last three months.​ </li><li>In the last 30 days, there have been no negative revisions of earnings estimates</li></ul>RECOMMENDATIONS<ul><li>The current average analyst rating on the shares is &#34;buy&#34; and the breakdown of recommendations is 7 &#34;strong buy&#34; or &#34;buy,&#34; 1 &#34;hold&#34; and no &#34;sell&#34; or &#34;strong sell.&#34; The average consensus recommendation for the healthcare facilities &amp; services peer group is also &#34;buy&#34; </li><li>Wall Street's median 12-month price target for LifeStance Health Group Inc is $8.75, about 28.6% above its last closing price of $6.25</li></ul>This summary was machine generated from LSEG data November 7 at 08:17 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)<div><table><tbody><tr><td>QUARTER ENDING</td><td>ESTIMATE </td><td>ACTUAL</td><td>BEAT, MET, MISSED</td></tr><tr><td>Sep. 30 2025 </td><td>-0.01</td><td>0.00</td><td>Beat</td></tr><tr><td>Jun. 30 2025 </td><td>-0.03</td><td>-0.01</td><td>Beat</td></tr><tr><td>Mar. 31 2025 </td><td>-0.03</td><td>0.00</td><td>Beat</td></tr><tr><td>Dec. 31 2024 </td><td>-0.03</td><td>-0.02</td><td>Beat</td></tr></tbody></table></div></div></div>

LFST

LifeStance Health Group Inc reported breakeven earnings per share for the quarter ended September 30, surpassing last year's EPS of -2 cents and analysts' expectations of a loss. Revenue increased by 16.3% to $363.81 million, exceeding the expected $355.60 million. The company achieved a net income of $1.08 million. Analyst ratings are predominantly "buy," with a median 12-month price target of $8.75, indicating a potential upside of 28.6% from the last closing price of $6.25.

LifeStance Health Group Inc reports results for the quarter ended September 30 - Earnings Summary